200 related articles for article (PubMed ID: 22019045)
1. In search of a cytostatic agent derived from the alkaloid lycorine: synthesis and growth inhibitory properties of lycorine derivatives.
Evdokimov NM; Lamoral-Theys D; Mathieu V; Andolfi A; Frolova LV; Pelly SC; van Otterlo WA; Magedov IV; Kiss R; Evidente A; Kornienko A
Bioorg Med Chem; 2011 Dec; 19(23):7252-61. PubMed ID: 22019045
[TBL] [Abstract][Full Text] [Related]
2. C1,C2-ether derivatives of the Amaryllidaceae alkaloid lycorine: retention of activity of highly lipophilic analogues against cancer cells.
Dasari R; Banuls LM; Masi M; Pelly SC; Mathieu V; Green IR; van Otterlo WA; Evidente A; Kiss R; Kornienko A
Bioorg Med Chem Lett; 2014 Feb; 24(3):923-7. PubMed ID: 24393582
[TBL] [Abstract][Full Text] [Related]
3. Lycorine, the main phenanthridine Amaryllidaceae alkaloid, exhibits significant antitumor activity in cancer cells that display resistance to proapoptotic stimuli: an investigation of structure-activity relationship and mechanistic insight.
Lamoral-Theys D; Andolfi A; Van Goietsenoven G; Cimmino A; Le Calvé B; Wauthoz N; Mégalizzi V; Gras T; Bruyère C; Dubois J; Mathieu V; Kornienko A; Kiss R; Evidente A
J Med Chem; 2009 Oct; 52(20):6244-56. PubMed ID: 19788245
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity studies on the lycorine pharmacophore: A potent inducer of apoptosis in human leukemia cells.
McNulty J; Nair JJ; Bastida J; Pandey S; Griffin C
Phytochemistry; 2009 May; 70(7):913-9. PubMed ID: 19464034
[TBL] [Abstract][Full Text] [Related]
5. Design, Synthesis and Structure-Activity Relationship Optimization of Lycorine Derivatives for HCV Inhibition.
Chen D; Cai J; Cheng J; Jing C; Yin J; Jiang J; Peng Z; Hao X
Sci Rep; 2015 Oct; 5():14972. PubMed ID: 26443922
[TBL] [Abstract][Full Text] [Related]
6. Amaryllidaceae alkaloids belonging to different structural subgroups display activity against apoptosis-resistant cancer cells.
Van Goietsenoven G; Andolfi A; Lallemand B; Cimmino A; Lamoral-Theys D; Gras T; Abou-Donia A; Dubois J; Lefranc F; Mathieu V; Kornienko A; Kiss R; Evidente A
J Nat Prod; 2010 Jul; 73(7):1223-7. PubMed ID: 20550100
[TBL] [Abstract][Full Text] [Related]
7. Synthetic analogues of the montanine-type alkaloids with activity against apoptosis-resistant cancer cells.
Govindaraju K; Ingels A; Hasan MN; Sun D; Mathieu V; Masi M; Evidente A; Kornienko A
Bioorg Med Chem Lett; 2018 Feb; 28(4):589-593. PubMed ID: 29409754
[TBL] [Abstract][Full Text] [Related]
8. Lycorine and its derivatives for anticancer drug design.
Lamoral-Theys D; Decaestecker C; Mathieu V; Dubois J; Kornienko A; Kiss R; Evidente A; Pottier L
Mini Rev Med Chem; 2010 Jan; 10(1):41-50. PubMed ID: 20105122
[TBL] [Abstract][Full Text] [Related]
9. Anti-dengue-virus activity and structure-activity relationship studies of lycorine derivatives.
Wang P; Li LF; Wang QY; Shang LQ; Shi PY; Yin Z
ChemMedChem; 2014 Jul; 9(7):1522-33. PubMed ID: 24574246
[TBL] [Abstract][Full Text] [Related]
10. Lycorine derivatives against Trichomonas vaginalis.
Giordani RB; Junior CO; de Andrade JP; Bastida J; Zuanazzi JA; Tasca T; de Almeida MV
Chem Biol Drug Des; 2012 Jul; 80(1):129-33. PubMed ID: 22260620
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antiplasmodial activity of lycorine derivatives.
Cedrón JC; Gutiérrez D; Flores N; Ravelo AG; Estévez-Braun A
Bioorg Med Chem; 2010 Jul; 18(13):4694-701. PubMed ID: 20627737
[TBL] [Abstract][Full Text] [Related]
12. Lycorine: A prospective natural lead for anticancer drug discovery.
Roy M; Liang L; Xiao X; Feng P; Ye M; Liu J
Biomed Pharmacother; 2018 Nov; 107():615-624. PubMed ID: 30114645
[TBL] [Abstract][Full Text] [Related]
13. Novel lycorine derivatives as anticancer agents: synthesis and in vitro biological evaluation.
Wang P; Yuan HH; Zhang X; Li YP; Shang LQ; Yin Z
Molecules; 2014 Feb; 19(2):2469-80. PubMed ID: 24566315
[TBL] [Abstract][Full Text] [Related]
14. Bulbispermine: a crinine-type Amaryllidaceae alkaloid exhibiting cytostatic activity toward apoptosis-resistant glioma cells.
Luchetti G; Johnston R; Mathieu V; Lefranc F; Hayden K; Andolfi A; Lamoral-Theys D; Reisenauer MR; Champion C; Pelly SC; van Otterlo WA; Magedov IV; Kiss R; Evidente A; Rogelj S; Kornienko A
ChemMedChem; 2012 May; 7(5):815-22. PubMed ID: 22389235
[TBL] [Abstract][Full Text] [Related]
15. Activity of lycorine analogues against the fish bacterial pathogen Flavobacterium columnare.
Tan CX; Schrader KK; Mizuno CS; Rimando AM
J Agric Food Chem; 2011 Jun; 59(11):5977-85. PubMed ID: 21517109
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of unnatural derivatives of narciclasine: 7-aza-nornarciclasine and its N-oxide.
Vshyvenko S; Reisenauer MR; Rogelj S; Hudlicky T
Bioorg Med Chem Lett; 2014 Sep; 24(17):4236-8. PubMed ID: 25108300
[TBL] [Abstract][Full Text] [Related]
17. Antibacterial activity and virtual screening by molecular docking of lycorine from Pancratium foetidum Pom (Moroccan endemic Amaryllidaceae).
Bendaif H; Melhaoui A; Ramdani M; Elmsellem H; Douez C; El Ouadi Y
Microb Pathog; 2018 Feb; 115():138-145. PubMed ID: 29253598
[TBL] [Abstract][Full Text] [Related]
18. Chemoenzymatic approaches to lycorine-type Amaryllidaceae alkaloids: total syntheses of ent-lycoricidine, 3-epi-ent-lycoricidine, and 4-deoxy-3-epi-ent-lycoricidine.
Matveenko M; Kokas OJ; Banwell MG; Willis AC
Org Lett; 2007 Aug; 9(18):3683-5. PubMed ID: 17685535
[TBL] [Abstract][Full Text] [Related]
19. Lycorine induces apoptosis of bladder cancer T24 cells by inhibiting phospho-Akt and activating the intrinsic apoptotic cascade.
Wang C; Wang Q; Li X; Jin Z; Xu P; Xu N; Xu A; Xu Y; Zheng S; Zheng J; Liu C; Huang P
Biochem Biophys Res Commun; 2017 Jan; 483(1):197-202. PubMed ID: 28042037
[TBL] [Abstract][Full Text] [Related]
20. Acetylcholinesterase inhibition within the lycorine series of Amaryllidaceae alkaloids.
Nair JJ; van Staden J
Nat Prod Commun; 2012 Jul; 7(7):959-62. PubMed ID: 22908593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
